Trial intelligence / Profile preview

Phase 2 trial of benvitimod cream in adults with atopic dermatitis

ChiCTR-IIR-17012153Phase 2Recruiting

Sponsor
Peking University People's Hospital
Start
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of tapinarof in atopic dermatitis (AD) (4 arms), sponsored by Peking University People's Hospital. Primary endpoint: Investigator's Global Assessment (IGA). Started Jun 2017; status: recruiting.

02

Drugs

tapinarof
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on ChiCTR-IIR-17012153.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IIR-17012153.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call